Dr. Trebley is Co-founder and CEO of Scioto Biosciences and Monon Bioventures.
Mr. Schulz is a serial entrepreneur with over 20 years of financial experience working with public accounting firms, Fortune 500 companies and small start-up companies.
Mark L. Heiman, Ph.D. has 20+ years at Eli Lilly & Co where he served as researcher and CSO of obesity drug discovery.
Kevin Meyer has over 10 years of experience in the life sciences industry, having invented, patented, and commercialized a diverse portfolio of technologies.
Jaswant S. Gidda, Ph. D. has extensive drug discovery and development experience in big pharma (Eli Lilly & Co) and as an entrepreneur in biotechnology industry.
Rob joined Scioto Biosciences in 2018 as the Director of Business Development and Strategy. Rob brings broad strategy and transaction advisory experience across the biopharma industry